Long COVID

Uses

How it works

Evidence quality

Highlighted claims

• Long COVID patients have SARS-CoV-2 viral particles still present in their bodies months after the initial infection. — Persistent Viral Particles and Interferon Dysregulation in Long COVID
• Approximately 5% of SARS-CoV-2 patients do not recover and develop Long COVID, affecting an estimated 70 million people globally. — Long COVID, ASIA Syndrome, and Autoimmunity: Insights from the 14th International Congress
• A complete autoimmune panel of 90 Long COVID patients versus 90 healthy controls revealed markedly elevated rates across multiple antibody types. — Long COVID, ASIA Syndrome, and Autoimmunity: Insights from the 14th International Congress
• Interferon levels remain significantly elevated in long COVID patients and do not return to normal baseline ranges. — Persistent Viral Particles and Interferon Dysregulation in Long COVID
• Long COVID patients produce autoantibodies against multiple neuronal and blood-brain barrier antigens, with IgM and IgA anti-BBB antibodies particularly elevated. — Long COVID, ASIA Syndrome, and Autoimmunity: Insights from the 14th International Congress
• No single autoimmune pattern defines Long COVID; five distinct clinical fingerprints were identified across patient cases. — Long COVID, ASIA Syndrome, and Autoimmunity: Insights from the 14th International Congress
• Ongoing immune dysregulation is part of the pathophysiology of long COVID. — Persistent Viral Particles and Interferon Dysregulation in Long COVID
• Treatments targeting autoantibodies through B-cell depletion or immunoadsorption are not curative because removed antibodies reappear within approximately three months without trigger elimination. — Long COVID, ASIA Syndrome, and Autoimmunity: Insights from the 14th International Congress
• EBV and HHV-6 together are implicated in approximately 50% of Long COVID patients. — Long COVID, ASIA Syndrome, and Autoimmunity: Insights from the 14th International Congress
• There is strong data supporting mitochondrial dysfunction as the primary mechanistic basis for long COVID fatigue. — Peptide Power: Longevity, Mitochondrial Function, and Leading-Edge Nutrients